Urokinase-type plasminogen activator gene regulation by polyomavirus middle-T antigen.

Abstract:

:Expression of polyomavirus middle-T antigen (middle-T) is involved in the formation of various tumors in vivo, e.g. hemangiomas and mammary gland tumors. Several genes have been shown to be activated in middle-T-expressing cells, but the underlying mechanisms have only been partially elucidated. Among the genes regulated by middle-T, the urokinase-type plasminogen activator (uPA) gene seems to be of primary importance for the development of the transformed phenotype. We have found that the uPA gene is highly expressed in eEnd2 cells derived from a hemangioma expressing middle-T. NIH3T3 cells show negligible levels of uPA mRNA but its expression was highly induced by infecting with a middle-T-expressing retrovirus. Middle-T did not affect uPA mRNA stability. Transient cotransfection experiments using a uPA-receptor gene construct and a middle-T expression vector showed that high uPA mRNA levels are due to increased uPA promoter activity. Analyses of various signaling molecules by transient cotransfection assays and in vitro kinase assays established that a signaling pathway involving c-Src, SOS, Ras, Raf-1 and ERK is activated by middle-T in NIH3T3 cells, resulting in the activation of the uPA gene promoter via PEA3/AP1 elements. In contrast, in eEND2 cells uPA gene induction is only partially dependent on this pathway, suggesting the involvement of additional signaling molecules in endothelial cells.

journal_name

Oncogene

journal_title

Oncogene

authors

Besser D,Urich M,Sakaue M,Messerschmitt A,Ballmer-Hofer K,Nagamine Y

subject

Has Abstract

pub_date

1995-12-07 00:00:00

pages

2383-91

issue

11

eissn

0950-9232

issn

1476-5594

journal_volume

11

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Wild-type p53 modulates apoptosis of normal, IL-3 deprived, hematopoietic cells.

    abstract::Apoptotic cell death is an active process which regulates the maintenance of the hematopoietic homeostasis. It has been reported that wild-type p53 (wt-p53) protein induces apoptosis in leukemia cells. To assess whether p53 is involved in the apoptotic process of normal hematopoietic cells, we introduced the temperatu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Blandino G,Scardigli R,Rizzo MG,Crescenzi M,Soddu S,Sacchi A

    更新日期:1995-02-16 00:00:00

  • Bone morphogenetic protein 3B silencing in non-small-cell lung cancer.

    abstract::Bone morphogenetic protein 3B (BMP3B) is a member of the TGF-beta superfamily. The BMP3B promoter sequence was previously identified as a target for aberrant DNA methylation in non-small-cell lung cancer (NSCLC). Aberrant DNA hypermethylation in the BMP3B promoter is associated with downregulation of BMP3B transcripti...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207441

    authors: Dai Z,Popkie AP,Zhu WG,Timmers CD,Raval A,Tannehill-Gregg S,Morrison CD,Auer H,Kratzke RA,Niehans G,Amatschek S,Sommergruber W,Leone GW,Rosol T,Otterson GA,Plass C

    更新日期:2004-04-29 00:00:00

  • Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes.

    abstract::Seventy lung tumors from 53 patients were analysed for alterations of myc family oncogenes, c-myc, N-myc and L-myc, to evaluate when activation of these genes occurs during tumor development. The 53 cases were 17 small cell carcinomas (SCCs), 18 adenocarcinomas, 12 squamous cell carcinomas (SqCs), 4 large cell carcino...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Yokota J,Wada M,Yoshida T,Noguchi M,Terasaki T,Shimosato Y,Sugimura T,Terada M

    更新日期:1988-06-01 00:00:00

  • Bruton's tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma.

    abstract::Aberrant activation of anaplastic lymphoma kinase (ALK) can cause sporadic and familial neuroblastoma. Using a proteomics approach, we identified Bruton's tyrosine kinase (BTK) as a novel ALK interaction partner, and the physical interaction was confirmed by co-immunoprecipitation. BTK is expressed in neuroblastoma ce...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0397-7

    authors: Li T,Deng Y,Shi Y,Tian R,Chen Y,Zou L,Kazi JU,Rönnstrand L,Feng B,Chan SO,Chan WY,Sun J,Zhao H

    更新日期:2018-11-01 00:00:00

  • The relationship among p53 oligomer formation, structure and transcriptional activity using a comprehensive missense mutation library.

    abstract::Tumor suppressor p53 forms a homo-tetramer through its COOH-terminal oligomerization domain and acts as a sequence-specific transcription factor. We have analysed the interrelation among the transcriptional activities, the structure and the cancer-related mutations in the oligomerization domain by using a comprehensiv...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208839

    authors: Kawaguchi T,Kato S,Otsuka K,Watanabe G,Kumabe T,Tominaga T,Yoshimoto T,Ishioka C

    更新日期:2005-10-20 00:00:00

  • The FoxO code.

    abstract::The FoxO family of Forkhead transcription factors plays an important role in longevity and tumor suppression by upregulating target genes involved in stress resistance, metabolism, cell cycle arrest and apoptosis. FoxO transcription factors translate a variety of environmental stimuli, including insulin, growth factor...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2008.21

    authors: Calnan DR,Brunet A

    更新日期:2008-04-07 00:00:00

  • Localization of a growth suppressor activity in MCF7 breast cancer cells to chromosome 17q24-q25.

    abstract::Chromosome 17 is one of the most frequently altered chromosomes in malignant breast cancer. At least four genes implicated in breast cancer reside on chromosome 17 (p53, 17p13; Her-2/neu/ERBB2, 17q12; BRCA1, 17q21; and nm23, 17q22). In addition, allelic imbalance has been described for at least five regions of chromos...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201073

    authors: Plummer SJ,Adams L,Simmons JA,Casey G

    更新日期:1997-05-15 00:00:00

  • Activation of MyoD-dependent transcription by cdk9/cyclin T2.

    abstract::Myogenic transcription is repressed in myoblasts by serum-activated cyclin-dependent kinases, such as cdk2 and cdk4. Serum withdrawal promotes muscle-specific gene expression at least in part by down-regulating the activity of these cdks. Unlike the other cdks, cdk9 is not serum- or cell cycle-regulated and is instead...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205493

    authors: Simone C,Stiegler P,Bagella L,Pucci B,Bellan C,De Falco G,De Luca A,Guanti G,Puri PL,Giordano A

    更新日期:2002-06-13 00:00:00

  • ROS release by PPARβ/δ-null fibroblasts reduces tumor load through epithelial antioxidant response.

    abstract::Tumor stroma has an active role in the initiation, growth, and propagation of many tumor types by secreting growth factors and modulating redox status of the microenvironment. Although PPARβ/δ in fibroblasts was shown to modulate oxidative stress in the wound microenvironment, there has been no evidence of a similar e...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-017-0109-8

    authors: Tan EHP,Sng MK,How ISB,Chan JSK,Chen J,Tan CK,Wahli W,Tan NS

    更新日期:2018-04-01 00:00:00

  • Regulation of phosphoglucomutase 1 phosphorylation and activity by a signaling kinase.

    abstract::We have identified a novel mechanism of cross-talk between cell signaling and metabolic pathways, whereby the signaling kinase p21-activated kinase 1 (Pak1) binds to, phosphorylates and enhances the enzymatic activity of phosphoglucomutase 1 (PGM), an important regulatory enzyme in cellular glucose utilization and ene...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207969

    authors: Gururaj A,Barnes CJ,Vadlamudi RK,Kumar R

    更新日期:2004-10-21 00:00:00

  • Use of the two hybrid system to detect the association of the protein-tyrosine-phosphatase, SHPTP2, with another SH2-containing protein, Grb7.

    abstract::SHPTP2 is a ubiquitously-expressed SH2-containing tyrosine phosphatase that is tyrosine phosphorylated in response to activation of various receptor and nonreceptor tyrosine kinases. SHPTP2 associates with the platelet-derived growth factor (PDGF) receptor after ligand stimulation, and binding of SHPTP2 to this recept...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Keegan K,Cooper JA

    更新日期:1996-04-04 00:00:00

  • Histone H1(S)-3 phosphorylation in Ha-ras oncogene-transformed mouse fibroblasts.

    abstract::Phosphorylation of linker histone H1(S)-3 (previously named H1b) and core histone H3 is elevated in mouse fibroblasts transformed with oncogenes or constitutively active mitogen-activated protein kinase (MAPK) kinase (MEK). H1(S)-3 phosphorylation is the only histone modification known to be dependent upon transcripti...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206029

    authors: Chadee DN,Peltier CP,Davie JR

    更新日期:2002-12-05 00:00:00

  • The carboxy terminus of the viral Jun oncoprotein is required for complex formation with the cellular Fos protein.

    abstract::The products of the proto-oncogenes c-jun and c-fos are known to form a complex in vivo. Complex formation appears to stabilize protein-DNA interactions and is thought to play an important functional role in transcriptional regulation. Here we show that the viral Jun oncoprotein, which differs structurally from cellul...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Bos TJ,Rauscher FJ 3rd,Curran T,Vogt PK

    更新日期:1989-02-01 00:00:00

  • p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc.

    abstract::We showed earlier that p300/CBP plays an important role in G1 progression by negatively regulating c-Myc and thereby preventing premature G1 exit. Here, we have studied the mechanism by which p300 represses c-Myc and show that in quiescent cells p300 cooperates with histone deacetylase 3 (HDAC3) to repress transcripti...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.181

    authors: Sankar N,Baluchamy S,Kadeppagari RK,Singhal G,Weitzman S,Thimmapaya B

    更新日期:2008-09-25 00:00:00

  • Characterization of a major colon cancer susceptibility locus (Ccs3) on mouse chromosome 3.

    abstract::Treatment of mice with the carcinogen azoxymethane (AOM) induces a number of lesions in the colon, including hyperplastic lesions, as well adenomas and carcinomas in situ. Inbred strains of mice show different responses to AOM-induced carcinogenesis. A/J mice are highly susceptible and develop a greater number of hype...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.369

    authors: Meunier C,Cai J,Fortin A,Kwan T,Marquis JF,Turbide C,Van Der Kraak L,Jothy S,Beauchemin N,Gros P

    更新日期:2010-02-04 00:00:00

  • Direct integrin alphavbeta6-ERK binding: implications for tumour growth.

    abstract::Blockade of the mitogen-activated protein (MAP) kinase pathway suppresses growth of colon cancer in vivo. Here we demonstrate a direct link between the extracellular signal-regulated kinase ERK2 and the growth-promoting cell adhesion molecule, integrin alphavbeta6, in colon cancer cells. Down-regulation of beta6 integ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205286

    authors: Ahmed N,Niu J,Dorahy DJ,Gu X,Andrews S,Meldrum CJ,Scott RJ,Baker MS,Macreadie IG,Agrez MV

    更新日期:2002-02-21 00:00:00

  • New insights into apoptosis signaling by Apo2L/TRAIL.

    abstract::Apoptosis ligand 2 tumor necrosis factor (TNF)-related apoptosis-inducing ligand (Apo2L/TRAIL) belongs to a small subset of proapoptotic protein ligands in the TNF superfamily. This subset, which also includes Fas ligand and TNF-alpha, can activate the extrinsic apoptotic cell death pathway on binding to cognate death...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.221

    authors: Gonzalvez F,Ashkenazi A

    更新日期:2010-08-26 00:00:00

  • Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.

    abstract::The RAF-mitogen-activated protein kinase kinase 1/2-extracellular signal-regulated kinase 1/2 (RAF-MEK1/2-ERK1/2) pathway is activated in many human tumours and can protect cells against growth factor deprivation; however, most such studies have relied upon overexpression of RAF or MEK constructs that are not found in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.335

    authors: Wickenden JA,Jin H,Johnson M,Gillings AS,Newson C,Austin M,Chell SD,Balmanno K,Pritchard CA,Cook SJ

    更新日期:2008-12-04 00:00:00

  • New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin.

    abstract::Telomeres are stabilized, and telomeric DNA is replenished, by the action of the ribonucleoprotein reverse transcriptase telomerase. Telomere capping functions include the ability of telomeres to protect chromosome ends from cellular DNA-damage responses such as cell cycle arrest or apoptosis. This property of telomer...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1205082

    authors: Chan SW,Blackburn EH

    更新日期:2002-01-21 00:00:00

  • Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma.

    abstract::Microsatellite-stable, near-diploid (MSI-CIN-) colorectal carcinomas have been reported, but it is not clear as to whether these tumours form a discrete group or represent one end of the distribution of MSI-CIN+ cancers. In order to address this question, we screened 23 MSI-CIN- colorectal cancers for gains and losses...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208194

    authors: Jones AM,Douglas EJ,Halford SE,Fiegler H,Gorman PA,Roylance RR,Carter NP,Tomlinson IP

    更新日期:2005-01-06 00:00:00

  • Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer.

    abstract::ID4 gene is a member of the inhibitor of DNA-binding (ID) family, which inhibits DNA binding of basic helix-loop-helix transcription factors. Certain human primary breast cancers reportedly have low or no expression of ID4 protein, but its role in carcinogenesis and cancer progression is unknown. To determine its poss...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208538

    authors: Umetani N,Mori T,Koyanagi K,Shinozaki M,Kim J,Giuliano AE,Hoon DS

    更新日期:2005-07-07 00:00:00

  • Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3.

    abstract::Ki-1 lymphoma is a subtype of human malignant lymphoma characterized by the expression of CD30 (Ki-1) and a peculiar morphology. It is occasionally accompanied by a unique reciprocal chromosomal translocation t(2;5)(p23;q35). A Ki-1 lymphoma cell line, AMS3, was established by maintaining biopsied tumor cells in SCID ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Shiota M,Fujimoto J,Semba T,Satoh H,Yamamoto T,Mori S

    更新日期:1994-06-01 00:00:00

  • JunD activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress.

    abstract::Ferritin is the major intracellular iron storage protein that sequesters excess free iron to minimize generation of iron-catalysed reactive oxygen species. We previously demonstrated that expression of ferritin heavy chain (ferritin H) was induced by pro-oxidants, which is a part of cellular antioxidant response to pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208901

    authors: Tsuji Y

    更新日期:2005-11-17 00:00:00

  • Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.

    abstract::While studying Bim, a BH3-only proapoptotic protein, we identified an approximately 36 kDa protein, which was abundantly expressed in all five strains of primary normal human prostate (NHP) epithelial cells but significantly reduced or lost in seven prostate cancer cell lines. The approximately 36 kDa protein was subs...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206196

    authors: Liu JW,Shen JJ,Tanzillo-Swarts A,Bhatia B,Maldonado CM,Person MD,Lau SS,Tang DG

    更新日期:2003-03-13 00:00:00

  • Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.

    abstract::A common characteristic of malignant cells derived from patients with Hodgkin's disease (HD) is a high level of constitutive nuclear NF-kappaB/Rel activity, which stimulates proliferation and confers resistance to apoptosis. We have analysed the mechanisms that account for NF-kappaB activation in a panel of Hodgkin/Re...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202351

    authors: Krappmann D,Emmerich F,Kordes U,Scharschmidt E,Dörken B,Scheidereit C

    更新日期:1999-01-28 00:00:00

  • Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1.

    abstract::Fanconi anemia is a hereditary cancer susceptibility disorder characterized at the cellular level by spontaneous chromosomal instability and specific hypersensitivity to DNA cross-linking agents such as mitomycin C. This phenotype suggests a possible role for the Fanconi anemia proteins in the repair of DNA lesions in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205656

    authors: Godthelp BC,Artwert F,Joenje H,Zdzienicka MZ

    更新日期:2002-07-25 00:00:00

  • Oncogenic Ras increases sensitivity of colon cancer cells to 5-FU-induced apoptosis.

    abstract::Despite the fact that objective response rates to 5-FU are as low as 20%, 5-FU remains the most commonly used drug for the treatment of colorectal cancer. The lack of understanding of resistance to 5-FU, therefore, remains a significant impediment in maximizing its efficacy. We used intestinal epithelial cells with an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208552

    authors: Klampfer L,Swaby LA,Huang J,Sasazuki T,Shirasawa S,Augenlicht L

    更新日期:2005-06-02 00:00:00

  • Expression of proto-oncogenes in embryonic, adult, and transformed tissue of Xiphophorus (Teleostei: Poeciliidae).

    abstract::In Xiphophorus the causative, primary cellular oncogene for melanoma formation has been assigned by classical genetics to a sex-chromosomal locus, designated Tu. Activation of Tu was proposed to be the result of the elimination of Tu-specific regulatory genes which normally suppress the transforming function in the no...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Mäueler W,Raulf F,Schartl M

    更新日期:1988-05-01 00:00:00

  • Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.

    abstract::The REL gene is amplified in many human B-cell lymphomas and we have previously shown that expression of REL from a retroviral vector can malignantly transform chicken spleen cells in vitro. To identify REL protein functions necessary for malignant transformation, we have performed deletion analysis on REL sequences e...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206801

    authors: Starczynowski DT,Reynolds JG,Gilmore TD

    更新日期:2003-10-09 00:00:00

  • PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein.

    abstract::Pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2) is a tumor suppressor that catalyzes the de-phosphorylation of the AGC kinases, while p27 acts as a tumor suppressor that regulates cell cycle, apoptosis, and cell motility. Our previous studies have identified that PHLPP2 participates in in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0374-1

    authors: Peng M,Wang J,Zhang D,Jin H,Li J,Wu XR,Huang C

    更新日期:2018-10-01 00:00:00